Format

Send to

Choose Destination
Neurol Clin Pract. 2018 Dec;8(6):486-491. doi: 10.1212/CPJ.0000000000000544.

Status epilepticus alert reduces time to administration of second-line antiseizure medications.

Author information

1
Departments of Neurology (MFV, JLC, KSD, RW-M, LBG, MB-O) and Statistics (CK, YX), University of Kentucky, Lexington; Department of Neurology (MFV), Brigham and Women's Hospital, Harvard Medical School, Boston, MA; and UK HealthCare Pharmacy Services (AMC), Lexington, KY.

Abstract

Background:

Status epilepticus (SE) is a neurologic emergency with high morbidity and mortality. Delays in SE treatment are common in clinical practice and can be associated with poorer outcomes. Our goal was to determine whether the implementation of an SE alert protocol improves time to administration of a second-line antiseizure medication (ASM) in hospitalized adults.

Methods:

We developed and implemented an inpatient SE alert system. A quasiexperimental cohort study was performed. We analyzed all patients aged 18-85 years who were managed at the University of Kentucky Medical Center using the SE alert protocol between March 2015 and June 2017 (n = 19). Controls were the first 20 consecutive patients treated for SE over the same time period, but who were managed with usual care (i.e., without SE alert protocol).

Results:

Time to administration of a second-line ASM was shorter with the use of the SE alert system (22.21 ± 3.44 minutes) compared to usual care (58.30 ± 6.72 minutes; p < 0.0001).

Conclusion:

Implementation of an SE alert system led to a marked improvement in time to administration of a second-line ASM.

Classification of evidence:

This study provides Class III evidence that for adult inpatients treated for SE, implementation of an SE alert protocol reduces time to administration of second-line ASM.

PMID:
30588378
PMCID:
PMC6294531
[Available on 2019-12-01]
DOI:
10.1212/CPJ.0000000000000544

Supplemental Content

Loading ...
Support Center